HCP
FMS icon

Hexagon Capital Partners’s Fresenius Medical Care FMS Stock Holding History

Hexagon Capital Partners’s Portfolio FMS Stock Details FMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47
Closed -$1.17K – 653
2025
Q1 		$1.17K Hold
47
– – ﹤0.01% 1516
2024
Q4 		$1.06K Buy
47
+21
+81% +$456 ﹤0.01% 1561
2024
Q3 		$554 Sell
26
-1
-4% -$20 ﹤0.01% 1400
2024
Q2 		$516 Sell
27
-97
-78% -$1.98K ﹤0.01% 1326
2024
Q1 		$2.39K Hold
124
– – ﹤0.01% 1127
2023
Q4 		$2.58K Hold
124
– – ﹤0.01% 1082
2023
Q3 		$2.67K Sell
124
-90
-42% -$2.19K ﹤0.01% 1014
2023
Q2 		$5.12K Buy
214
+5
+2% +$115 ﹤0.01% 895
2023
Q1 		$4.44K Sell
209
-46
-18% -$881 ﹤0.01% 907
2022
Q4 		$4.17K Buy
255
+119
+88% +$1.76K ﹤0.01% 948
2022
Q3 		$2K Buy
136
+35
+35% +$662 ﹤0.01% 1097
2022
Q2 		$3K Buy
+101
New +$3.02K ﹤0.01% 898

Other funds holding FMS

Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hexagon Capital Partners's FMS Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Fresenius Medical Care (FMS) in Q2 2025, closing a stake of 47 shares — an estimated $1.17K sold.

Hexagon Capital Partners first reported a position in FMS in Q2 2022 and held it in 12 quarters. The position peaked at $5.12K in Q2 2023. 207 funds tracked by Wall St. Rank hold FMS as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Fresenius Medical Care position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 47 Fresenius Medical Care shares in Q2 2025, an estimated $1.17K.
  • Hexagon Capital Partners first reported a position in Fresenius Medical Care in Q2 2022 and held it in 12 quarters.
  • Hexagon Capital Partners's Fresenius Medical Care position peaked at $5.12K in Q2 2023.
  • 207 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.